If you've tried multiple antidepressants and still struggle with depression, you're not alone. About 1 in 3 people with depression don't find relief from traditional oral medications. That's where Spravato® comes in, a breakthrough treatment designed for adults with treatment-resistant depression (TRD).
What is Spravato?
Spravato is the only FDA-approved nasal spray for TRD. It works differently than traditional antidepressants by targeting glutamate, a chemical messenger in the brain linked to mood regulation. Spravato is used alongside an oral antidepressant and is administered under medical supervision in a certified healthcare setting.
What to Expect with Spravato
-
Rapid Relief: Many patients report improvement in symptoms within 24 hours to 4 weeks.
-
Monitored Care: You'll be observed for at least 2 hours after each dose to ensure safety with this medication.
-
Supportive Environment: Our pharmacy partners with certified clinics to ensure you receive compassionate and professional care.
Safety and Side Effects
Spravato may cause:
-
Dizziness or sedation
-
Feeling disconnected from reality (dissociation)
-
Increased blood pressure
-
Nausea or vomiting
Because of these effects, Spravato is only available through a Risk Evaluation and Mitigation Strategy (REMS) program. Your provider will guide you through every step. Contact us if you'd like more information on Spravato or finding a provider.
If you or a loved one are experiencing suicidal thoughts, please seek help immediately. Spravato is not a substitute for emergency care.